We’re not about quick fixes. We take a different approach – one that drives lasting change in the fight against serious chronic diseases. For more than 100 years, we have relentlessly pursued unexplored paths to long-term health.
From developing innovative solutions to creating innovative ways to get these medicines to people, we’re driven by a belief that real change happens when you break the status quo. Which is how we’ve reached over 11 million people in the U.S. alone.
Our focus on solving the world's most urgent health challenges influences our approach. Making long-term investments in the U.S. to fuel research and development, we are driven by our purpose to promote long-term health.
- Cardiovascular Disease
- Diabetes
- Obesity
- Rare Diseases
The day our founders secured the rights to produce insulin was the start of our company – and the beginning of our first partnership. Today, we work with scientists, institutions, startups and biotech innovators to turn bold ideas into life-changing solutions, always keeping patients at the heart of everything we do.
Improving access to medicines has always been a core part of our unordinary commitment to better care—and it continues to be central to our efforts to defeat serious chronic conditions. We recognize there’s still more to be done to ensure people get the medicines they need. That’s why we continuously pursue innovative opportunities and solutions to improve access and affordability for everyone.
Sometimes the best path to discovery is through open collaboration. From our innovation challenges to the sharing of our molecular compounds for preclinical research, we aim to create new innovation ecosystems that accelerate new medicine discovery and digital health solutions. It’s just another way we bring the unordinary into our everyday.
